| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,580 |
1,206 |
$726.34 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,107 |
1,068 |
$37.50 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
2,069 |
1,815 |
$12.00 |
| 80061 |
Lipid panel |
1,666 |
1,662 |
$0.00 |
| 82540 |
|
684 |
683 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
115 |
114 |
$0.00 |
| 86703 |
|
719 |
714 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
86 |
82 |
$0.00 |
| 84439 |
|
30 |
28 |
$0.00 |
| 84450 |
|
106 |
106 |
$0.00 |
| 3078F |
|
608 |
532 |
$0.00 |
| 82274 |
|
265 |
265 |
$0.00 |
| 84460 |
|
86 |
86 |
$0.00 |
| 3077F |
|
180 |
160 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
26 |
26 |
$0.00 |
| 99442 |
|
67 |
67 |
$0.00 |
| 99215 |
Prolong outpt/office vis |
12 |
12 |
$0.00 |
| 85027 |
|
974 |
965 |
$0.00 |
| 1111F |
|
208 |
173 |
$0.00 |
| 99443 |
|
666 |
620 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
1,315 |
1,266 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
820 |
817 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
686 |
684 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
3,897 |
3,629 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,400 |
2,388 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
953 |
943 |
$0.00 |
| 3079F |
|
164 |
152 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
725 |
685 |
$0.00 |
| 82043 |
|
684 |
683 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
115 |
114 |
$0.00 |
| 3074F |
|
477 |
434 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
381 |
376 |
$0.00 |
| 86140 |
|
14 |
14 |
$0.00 |
| 3075F |
|
165 |
155 |
$0.00 |
| 81001 |
|
27 |
27 |
$0.00 |
| 1220F |
|
320 |
312 |
$0.00 |
| 90656 |
|
22 |
22 |
$0.00 |
| 86780 |
|
49 |
49 |
$0.00 |
| 86593 |
|
73 |
71 |
$0.00 |
| 3044F |
|
230 |
229 |
$0.00 |
| 90686 |
|
37 |
37 |
$0.00 |
| 3080F |
|
46 |
41 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
24 |
24 |
$0.00 |
| 4450F |
|
68 |
66 |
$0.00 |
| 94760 |
|
12 |
12 |
$0.00 |
| 87522 |
Neg quan hep c or qual rna |
41 |
40 |
$0.00 |